Data published late last week in the Centers for Disease Control and Prevention's (CDC's) Morbidity and Mortality Weekly Report (MMWR) detailed public school costs for recommended COVID-19 mitigation strategies, which averaged $442 per student but varied widely.
Investigators with the United Kingdom's RECOVERY trial reported yesterday that a preliminary analysis of data from the azithromycin arm of the trial showed the antibiotic had no impact on clinical outcomes in hospitalized COVID-19 patients.
About 2 in 10 US school districts have said they will continue, or are considering continuing, distance learning after the COVID-19 pandemic ends, citing student and parent demand, according to a Rand Corporation study released yesterday.
A study published today in the Centers for Disease Control and Prevention's (CDC's) Morbidity and Mortality Weekly Report (MMWR) highlights factors that may increase the risk of infection with SARS-CoV-2, the virus that causes COVID-19, among US poultry facility workers—especially those who are foreign-born.
A Latin American study of children with COVID-19–related multisystem inflammatory syndrome (MIS-C) in The Pediatric Infectious Disease Journal found higher rates of the disease among Latin/Hispanic children compared with other global estimates.
Data show a 20% higher risk of developing diabetes following COVID compared to other upper respiratory viruses.
Preschoolers of parents who had been vaccinated against COVID appeared to have 97% protection against Delta and 79% protection against Omicron.
As of July, less than 4% of US children 6 months to 4 years old had received at least one dose of COVID-19 vaccine.
"The benefits of vaccination against SARS-CoV-2 in reducing the severity of COVID-19, hospital admission, and deaths far outweigh the risk of developing myocarditis," the authors say.
MRI results show significant changes in the brain linked to fatigue, insomnia, anxiety, depression, headaches, and cognitive problems.
The antiviral drug remdesivir and corticosteroids were tied to better outcomes in COVID-19 patients admitted directly to a hospital ward.
Adult US COVID-19 patients who received the antiviral drug Paxlovid within 5 days after diagnosis had a 51% lower hospitalization rate than nonrecipients.
Adapting COVID-19 standards of care to evolving information about optimal treatments may have shortened recovery and reduced deaths.
Compared to 2020, mortality rates due to COVID-19 among young adults increased significantly in 2021.
The 47 women were given Paxlovid a median of 1 day after COVID-19 symptom onset.
COVID-19 infection is tied to increased liver stiffness, a sign of possible long-term liver injury.
Over half of those who had COVID-19 in 2020 reported persistent long-COVID symptoms and continued use of health services.
Data reflect about an 11% incidence of residual lung damage known as interstitial lung disease after COVID-19 hospitalization.
"It is clear that ... healthcare services and policy need to prioritise long Covid care."
A group of experts from Stanford and Harvard universities, as well as the Dana-Farber Cancer Institute, propose a new model for measuring direct, indirect, and excess deaths from COVID-19 in the United States, and they say relying solely on death certificates likely undercounts the true death toll COVID-19 has taken in the United States. Their proposal is published in the Annals of Internal Medicine.
Preliminary data from a small study published today in Nature Medicine suggests convalescent plasma may have some efficacy in patients with severe COVID-19.
Live SARS-CoV-2, the virus that causes COVID-19, was isolated from air samples collected 2 to 4.8 meters (6.6 to 15.7 feet) away from two coronavirus patients—one recently released and one newly admitted—in a single hospital room, according to a study published yesterday in the International Journal of Infectious Diseases.
High SARS-CoV-2 viral load at hospital admission may place patients with and without cancer at higher risk for death, a new multicenter observational study published in Cancer Cell suggests.
Increased age, male sex, non-Hispanic black ethnicity, and certain underlying health conditions are associated with a greater risk of hospitalization from COVID-19, according to an analysis of data from more than 5,000 hospitalized adults. A group based at the Centers for Disease Control and Prevention (CDC) reported its findings today in Clinical Infectious Diseases.
Acute stress and depression rates rose in US adults as COVID-19 cases and deaths accumulated from mid-March to mid-April, largely related to preexisting mental and physical conditions and stressors such as job and wage loss, according to a study of 6,514 people from three large, nationally representative cohorts.
